Arquivamento definitivo - Art. 33 da LPI
#11.1.1
04/28/2009
RPI 1999
Application data
Number
PI0416588Type
Filing
Publication
PCT
EP2004012877 The application was abandoned: examination was not requested within the 36 months following the 11/12/2004 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 04/28/2009. We update with every new RPI gazette, published weekly.
Applicants
Novartis AG
CH
Inventors
F. P. (pessoa física)
FR
S. S. (pessoa física)
US
W. D. (pessoa física)
US
IPC Classification
Priority claims
US
60/519.965 · 11/14/2003
Abstract
"USO FARMACÊUTICO ADICIONAL". A presente invenção refere-se a um composto (S)-N-(1-carbóxi-2-metilprop-1-il)-N-pentanoil-N-[2 (1H-tetrazol-5-il)bifenil-4-ilmetil]amina (valsartan) de fórmula (I) ou um sal do mesmo, em particular um sal farmaceuticamente aceitável do mesmo, pode ser usado para tratar a síndrome nefrótica.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
04/28/2009
RPI 1999
#11.1
09/02/2008
RPI 1965
#1.3
01/30/2007
RPI 1882
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.